Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Suppressing certain hormones might help prevent prostate cancer.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

New compounds may help treat prostate cancer by reducing cell growth.

Neurosteroids may help treat disorders with too much dopamine activity.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Androgens and DHEA can help prevent breast cancer and improve health in women.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.